Elvitegravir (GS-9137, JTK-303) - ≥99%, high purity , Human immunodeficiency virus type 1 integrase inhibitor, CAS No.697761-98-1, Human immunodeficiency virus type 1 integrase inhibitor
Elvitegravir (GS-9137, JTK-303) - ≥99%, high purity , Human immunodeficiency virus type 1 integrase inhibitor, CAS No.697761-98-1, Human immunodeficiency virus type 1 integrase inhibitor
Elvitegravir is an inhibitor of HIV-1 integrase which is responsible for the strand-transfer step of integration. Studies indicate that Elvitegravir is effective against HIV-1 strains that are resistant to other agents such as nucleotide reverse-transcrip
Storage Temp
Store at 2-8°C
Shipped In
Wet ice
This product requires cold chain shipping. Ground and other economy services are not available.
Grade
Moligand™
Action Type
INHIBITOR
Mechanism of action
Human immunodeficiency virus type 1 integrase inhibitor
Product Description
Elvitegravir (GS-9137, JTK-303) is an HIV integrase inhibitor for HIV-1 IIIB, HIV-2 EHO and HIV-2 ROD with IC50 of 0.7 nM, 2.8 nM and 1.4 nM, respectively. An HIV-1 integrase inhibitor
This compound belongs to the class of organic compounds known as quinoline carboxylic acids. These are quinolines in which the quinoline ring system is substituted by a carboxyl group at one or more positions.
1. Djoumbou Feunang Y, Eisner R, Knox C, Chepelev L, Hastings J, Owen G, Fahy E, Steinbeck C, Subramanian S, Bolton E, Greiner R, and Wishart DS. ClassyFire: Automated Chemical Classification With A Comprehensive, Computable Taxonomy. Journal of Cheminformatics, 2016, 8:61.